You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH):擬將1835.26萬元節餘募集資金永久性補充流動資金
格隆匯 08-30 19:37

格隆匯 8 月 30日丨海利生物(603718.SH)公告,公司在平安銀行上海南京西路支行開設的募集資金專用賬户:11014761363007,涉及公司兩個募集資金項目“動物疫苗產業化技術改造項目”和“全資收購上海捷門生物技術有限公司項目”。根據公司2019年度股東大會審議通過的《關於公司部分募投項目結項並將節餘募集資金永久性補充流動資金的議案》,“動物疫苗產業化技術改造項目”已經結項且該項目節餘募集資金1688.88萬元已經轉出至公司基本户。

2020年6月23日,平安銀行上海南京西路支行募集資金專户中應用於支付“全資收購上海捷門生物技術有限公司項目”的募集資金7000.萬元已經支付完畢。因此,公司於2020年8月28日召開第三屆董事會第十九次會議、第三屆監事會第十四次會議審議通過《關於公司擬註銷部分募集資金專户並將節餘資金永久性補充流動資金的議案》,同意將該募集資金專户進行銷户,並將賬户內節餘資金:1835.26萬元(含利息收入,實際金額應以資金轉出當日專户餘額為準)永久性補充流動資金,轉入海利生物基本户。

本事項尚需提交公司股東大會審議。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account